Clinical outcomes for Medicaid recipients with early-onset breast cancer: An analysis of the National Inpatient Sample.
Abstract
11180 Background: Despite recent global decreases in overall cancer incidence, the incidence of early-onset breast cancer (EOBC) is steadily increasing globally. Limited data is available on the comorbid correlations for this unfortunately expanding population. We sought to examine the national inpatient sample database to describe in-hospital outcomes among Medicaid recipients with EOBC. Methods: Data were extracted from the National Inpatient Sample (NIS) Database for 2019 and 2020. The NIS was searched for hospitalizations of adult patients with EOBC, defined as all-cause breast cancer in patients 50 years old or younger. We then examined the outcomes of patients who were noted to be active Medicaid recipients. Multivariate logistic was used to adjust for confounders. The primary outcome was inpatient mortality and secondary outcomes were annotated accordingly. SPSS software was used for statistical analysis, and all results were powered to p<0.001. Results: This study included 10,764 patients with EOBC, of which 3145 (29.2%) were on Medicaid. Multivariate regression showed that Medicaid patients with EOBC had higher inpatient mortality (OR 1.507, CI 1.406-1.616, p<0.001). On secondary analysis, Medicaid patients with EOBC were more likely to have systemic lupus erythematosus (OR 1.194, CI 1.080-1.319), anemia (OR 1.465, CI 1.433-1.498), thrombocytopenia (OR 1.440, CI 1.377-1.507), hypertension (OR 1.578, CI 1.461-1.704), chronic kidney disease (OR 1.343, CI 1.253-1.440), acute renal failure (OR 1.506, CI 1.432-1.584), pancreatitis (OR 1.420, CI 1.221-1.651), pericarditis (OR 1.394, CI 1.282-1.515), intracranial hemorrhage (OR 1.429, CI 1.225-1.665), severe liver disease (OR 1.504, CI 1.458-1.550), peptic ulcer disease (OR 1.436, CI 1.271-1.623), obstructive sleep apnea (OR 1.413, CI 1.313-1.521), leukemia (OR 1.310, CI 1.098-1.564), lymphoma (OR 1.737, CI 1.296-2.328), all-cause arrhythmias (OR 1.448, CI 1.342-1.563), all-cause shock (OR 1.478, CI 1.290-1.693), all-cause heart block (OR 1.294, CI 1.103-1.519), all-cause sepsis (OR 1.549, CI 1.496-1.603), all-cause coagulopathy (OR 1.457, CI 1.362-1.558), all-cause heart failure (OR 1.587, CI 1.467-1.717), all-cause stroke (OR 1.450, CI 1.342-1.566), and all-cause myocardial infarction (OR 1.766, CI 1.503-2.075). Conclusions: In this nationally representative, populationābased retrospective cohort study, Medicaid recipients with EOBC were associated with higher mortality and worse outcomes.
Article Details
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
Authors (5)
Vineet Polineni
1Jefferson Health - New Jersey, Stratford, United States
Danielle Claire Thor
Jefferson Health New Jersey, Stratford, NJ
Tony Elias
2Temple University, Philadelphia, United States
Ben Brik
1Jefferson Health - New Jersey, Stratford, United States
Mahija Cheekati
3Ochsner Clinic Foundation, New Orleans, United States